Health care industry
Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding
Prenuvo’s clinic in New York City, New York. Courtesy of Prenuvo Preventative health startup Prenuvo on Thursday announced it will offer three new health assessments in addition to its flagship full-body MRI scan. The company is launching a detailed blood test, neurological scan and body composition analysis that was approved by the U.S. Food and […]
Read More
U.S. investors, Big Pharma race to find new medicines in China
A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. \ Nurphoto | Nurphoto | Getty Images A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than […]
Read More
Healthy Returns: What to know about Trump’s NIH funding cuts
Biotech researchers. Janiecbros | E+ | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Trump administration is trying to implement major funding cuts to the National Institutes of Health that would cap […]
Read More
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic’ practices
David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023. Al Drago | Bloomberg | Getty Images CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s Caremark unit, which are widely accused of inflating prescription medication […]
Read More
Neuralink competitor Paradromics secures investment from Saudi Arabia’s Neom
Paradromics scientists at work Source: Paradromics Texas-based neurotech startup Paradromics on Wednesday announced a strategic partnership with Saudi Arabia’s Neom and said it will establish a Brain-Computer Interface Center of Excellence in the region. Neom is a developing area within northwest Saudi Arabia that’s touted as “a hub for innovation,” according to its website. The […]
Read More
Apple launches first major health study in 5 years. Here’s how you can opt in
Apple CEO Tim Cook delivers remarks before the start of an Apple event at the Apple headquarters in Cupertino, California, on Sept. 9, 2024. Justin Sullivan | Getty Images Apple is deepening its investment in health-care research by launching a new, years-long project called the Apple Health Study, the company announced on Wednesday. The study […]
Read More
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth. But the biotech company’s […]
Read More
CVS results top estimates even as high medical costs drag down insurance unit
An exterior view of a CVS pharmacy in Danville, Pennsylvania. Paul Weaver | Lightrocket | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs. The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6 […]
Read More
Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma
President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC. Oliver Contreras | Afp | Getty Images President Donald Trump likely won’t do away with a landmark process that allows Medicare to negotiate drug prices with manufacturers, even as he moves to erase Joe […]
Read More
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients
Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that’s slated to run during the Super Bowl on Sunday. Sens. Dick Durbin, D-Ill., and Roger Marshall, R-Kan., wrote a letter to the U.S. Food and Drug Administration on Friday expressing concerns over an “upcoming advertisement” that “risks misleading […]
Read More